Rare diseases
Investigational molecules
Locations
279 conditions with trials, the busiest first
686 trials across Europe, recruiting first
Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection
BelgiumStudy on Ganciclovir and Valganciclovir for Preventing Cytomegalovirus in High-Risk Heart Surgery Patients
SpainStudy on Bulevirtide Treatment for Patients with Chronic Hepatitis D
AustriaStudy on Montelukast for COVID-19 Patients at Higher Risk in Primary Care
The NetherlandsStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
SpainStudy Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens
FranceStudy on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia
EstoniaStudy on the V116 Vaccine for Adults Aged 18-64 at Increased Risk of Pneumococcal Infection
PolandStudy on Rezafungin Acetate for Children with Fungal Infections Aged Birth to Under 18 Years
GermanyStudy on Avibactam and Drug Combination for Treating Severe Infections in Patients
GreeceStudy on the Effects of S-217622 for Adults Hospitalized with COVID-19
DenmarkStudy on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
FranceThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
